A very short asymmetric synthesis of enantiomerically pure methyl substituted tetrahydro-3-benzazepines

Tetrahedron Asymmetry

Volumn 19, Issue 13, 2008, Pages 1613-1616

  Masood Husain, S ^a   Fröhlich, Roland ^b   Wünsch, Bernhard ^a  

^a INST OF REPRO MED OF THE UNIV   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 4 METHYLTETRAHYDRO 3 BENZAZEPINE; 2 METHYLTETRAHYDRO 3 BENZAZEPINE; 3 BENZAZEPINE DERIVATIVE; ALUMINUM CHLORIDE; BENZENE DERIVATIVE; GLYCINE DERIVATIVE; OXOACID; PHENYLGLYCINOL; TETRAHYDRO 3 BENZAZEPINE DERIVATIVE;

ARTICLE; ASYMMETRIC SYNTHESIS; BENZYLATION; CRYSTAL STRUCTURE; DIASTEREOISOMER; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HYDROGENOLYSIS; POLYMERIZATION; PRIORITY JOURNAL; REDUCTION; STEREOCHEMISTRY; STRUCTURE ANALYSIS; SUBSTITUTION LINE; SUBSTITUTION REACTION; X RAY CRYSTALLOGRAPHY;

EID: 48949114892     PISSN: 09574166     EISSN: 1362511X     Source Type: Journal    
DOI: 10.1016/j.tetasy.2008.06.016     Document Type: Article

References (30)

1. Weinstock J., Hieble J.P., and Wilson III J.W. Drug Future 10 (1985) 645-697
2. Kawase M., Saito S., and Motohasho N. Int. J. Antimicrob. Agents 14 (2000) 193-194
3. Sorbera L.A., and Castaner J. Drug Future 28 (2003) 652-658
4. Pettersson I., Liljefors T., and Bogeso K. J. Med. Chem. 33 (1990) 2197-2204
5. Kaiser C., Dandridge P.A., Garvey E., Hahn R.A., Sarau H.M., Setler P.E., Bass L.S., and Clardy J. J. Med. Chem. 25 (1982) 697-703
6. Micheli F., Bonanomi G., Braggio S., Capelli A.M., Celestini P., Damiani F., Di Fabio R., Donati D., Gagliardi S., Gentile G., Hamprecht D., Petrone M., Radaelli S., Tedesco G., Terreni S., Worby A., and Heidbreder C. Bioorg. Med. Chem. Lett. 18 (2008) 901-907
7. Yu Y., Wang J., Sun P.H., Guo Y., Zhang Z., Jin G., and Zhen X. J. Neurochem. 104 (2008) 946-956
8. Smith B.M., Smith J.M., Tsai J.H., Schultz J.A., Gilson C.A., Estrada S.A., Chen R.R., Park D.M., Prieto E.B., Gallardo C.S., Sengupta D., Thomsen W.J., Saldana H.R., Whelan K.T., Menzaghi F., Webb R.R., and Beeley N.R.A. Biorg. Med. Chem. Lett. 15 (2005) 1467-1470
9. Smith B.M., Smith J.M., Tsai J.H., Schultz J.A., Gilson C.A., Estrada S.A., Chen R.R., Park D.M., Prieto E.B., Gallardo C.S., Sengupta D., Dosa P.I., Covel J.A., Ren A., Webb R.R., Beeley N.R.A., Martin M., Morgan M., Espitia S., Saldana H.R., Bjenning C., Whelan K.T., Grottick A.J., Menzaghi F., and Thomsen W.J. J. Med. Chem. 51 (2008) 305-313
10. Gnanalingham K.K., Hunter A.J., Jenner P., and Marsden C.D. Psychopharmacology 117 (1995) 403-412
11. Medhurst A.D., Atkins A.R., Beresford I.J., Brackenborough K., Briggs M.A., Calver A.R., Cilia J., Cluderay J.E., Crook B., Davis J.B., Davis R.K., Davis R.P., Dawson L.A., Foley A.G., Gartlon J., Gonzalez M.I., Heslop T., Hirst W.D., Jennings C., Jones D.N.C., Lacroix L.P., Martyn A., Ociepka S., Ray A., Regan C.M., Roberts J.C., Schogger J., Southam E., Stean T.O., Trail B.K., Upton N., Wadsworth G., Wald J.A., White T., Witherington J., Woolley M.L., Worby A., and Wilson D.M. J. Pharm. Exp. Therap. 321 (2007) 1032-1045
12. Krull O., and Wünsch B. Bioorg. Med. Chem. 12 (2004) 1439-1451
13. Wirt U., Fröhlich R., and Wünsch B. Tetrahedron: Asymmetry 16 (2005) 2199-2202
14. Wirt U., Schepmann D., and Wünsch B. Eur. J. Org. Chem. (2007) 462-475
15. Watkins J.C., and Jane D.E. Br. J. Pharmacol. 147 (2006) 100-108
16. Bräuner-Osborne H.B., Egebjerg J., Nielsen E., Madsen U., and Krogsgaard-Larsen P. J. Med. Chem. 43 (2000) 2609-2645
17. Meyers A.I., Downing S.V., and Weiser M.J. J. Org. Chem. 66 (2001) 1413-1419
18. Husain, S. M.; Wünsch, B. Synthesis 2008, in press.
19. In the following references, compound 4 is mentioned. However a preparative procedure and spectroscopic and analytical data are not available. Bobranski B., and Konieczny M. Pol. Roczniki Chemii 36 (1962) 639-644
20. Konieczny M. Pol. Bull Acad. Polon. Sci. Ser. Sci. Chim. 7 (1959) 229-233
21. Burgess L.E., and Meyers A.I. J. Org. Chem. 57 (1992) 1656-1662
22. The de was determined by chiral HPLC, using CHIRALPAK AD-H column, isopropanol/n-hexane, flow rate 1 mL/min.
23. 3), 2.72-2.91 (m, 5H, 1-H/2-H/4-H/5-H), 3.01 (ddd, J = 14.7/10.6/1.9 Hz, 1H, 4-H), 3.23 (ddd, J = 12.9/6.5/2.90 Hz, 1H, 5-H), 7.06-7.13 (m, 4H, Ph-CH). A signal for the NH proton could not be detected.
24. 2Ph), 3.23 (dd, J = 13.7/5.4 Hz, 1H, 2-H), 3.32 (m, 1H, 1-H). 7.10-7.32 (m, 9H, arom).
25. 'collect' data collection software. Nonius, B. V. Delft, The Netherlands, 1998.
26. Otwinowski Z., and Minor W. Methods Enzymol. 276 (1997) 307-326
27. Otwinowski Z., Borek D., Majewski W., and Minor W. Acta Crystallogr., Sect. A 59 (2003) 228-234
28. Sheldrick G.M. Acta Crystallogr., Sect. A 46 (1990) 467-473
29. Sheldrick G.M. Acta Crystallogr., Sect. A 64 (2008) 112-122
30. Keller E. schakal-A Computer Program for the Graphic Representation of Molecular and Crystallographic Models (1997), Universität Freiburg